# Aspirin Eugenol Ester Alleviates Gastric Injury by Inhibiting Ferroptosis and Oxidative Stress

**Authors:** Qi Tao, Zhijie Zhang, Ji Feng, Liping Fan, Yajun Yang, Jianyong Li

PMC · DOI: 10.3390/antiox15020225 · Antioxidants · 2026-02-09

## TL;DR

Aspirin eugenol ester (AEE) protects the stomach from alcohol-induced damage by reducing inflammation, oxidative stress, and cell death.

## Contribution

AEE is shown to alleviate gastric injury through inhibition of ferroptosis and oxidative stress pathways.

## Key findings

- AEE significantly reduced ethanol-induced gastric mucosal injury and restored mucus secretion.
- AEE inhibited NF-κB activation and reduced inflammatory cytokine expression.
- AEE enhanced antioxidant levels and suppressed ferroptosis by modulating Nrf-2/GPX4 pathways.

## Abstract

Gastric ulcer (GU) is a common upper gastrointestinal disorder characterized by oxidative stress and inflammatory responses, which significantly impact the patient’s quality of life and pose a serious challenge to public health. Excessive and chronic alcohol consumption are considered primary contributing factors to gastric ulcer. Pharmacodynamic and pharmacological experiments showed that aspirin eugenol ester (AEE) had good anti-inflammatory and anti-oxidant effects. Therefore, it was speculated that AEE could alleviate ethanol-induced gastric mucosal injury through anti-inflammatory and antioxidant pathways. This study aimed to systematically evaluate the effect of AEE on ethanol-induced gastric mucosal injury using in vivo and in vitro experiments. In a gastric injury model induced by ethanol, H&E staining, AB-PAS staining, RT-PCR, immunohistochemistry, and a series of other molecular biological assays and omics techniques were employed to investigate AEE potential mechanisms. The results revealed extensive necrosis in the gastric mucosa of the ethanol group with a marked reduction in mucus secretion on the mucosal surface and a significantly decreased expression of ZO-1, claudin-1, and occludin, while AEE exhibited a significant protective effect when compared to ethanol group. AEE inhibited NF-κB pathway activation and reduced the expression of inflammatory cytokines. AEE significantly enhanced superoxide Dismutase (SOD) levels and reduced the ethanol-induced increases in reactive oxygen species (ROS), malondialdehyde (MDA), and lipid peroxidation (LPO) levels by reversing the ethanol-induced decline in Nrf-2 expression. AEE also mitigated cellular damage by inhibiting ferroptosis in the cells. AEE significantly improved the metabolic profiles of gastric tissue and serum. AEE exerts gastric protective effects by synergistically modulating multiple pathways and biological processes. AEE can enhance antioxidant capacity and inhibit ferroptosis by activating the Nrf-2/GPX4 pathway, alleviate inflammatory responses by suppressing the NF-κB pathway, and simultaneously maintain gastric mucosal barrier integrity through regulation of metabolic reprogramming and enhancement of tight junction function.

## Linked entities

- **Genes:** TJP1 (tight junction protein 1) [NCBI Gene 7082], CLDN7 (claudin 7) [NCBI Gene 1366], si:ch73-61d6.3 (uncharacterized si:ch73-61d6.3) [NCBI Gene 103182021], GABPA (GA binding protein transcription factor subunit alpha) [NCBI Gene 2551], GPX4 (glutathione peroxidase 4) [NCBI Gene 2879], NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790]
- **Chemicals:** aspirin eugenol ester (PubChem CID 25157143), ethanol (PubChem CID 702), malondialdehyde (PubChem CID 10964)
- **Diseases:** gastric ulcer (MONDO:0001126)

## Full-text entities

- **Genes:** Ppara (peroxisome proliferator activated receptor alpha) [NCBI Gene 25747] {aka PPAR}, Bax (BCL2 associated X, apoptosis regulator) [NCBI Gene 24887], Bbc3 (Bcl-2 binding component 3) [NCBI Gene 317673] {aka Puma}, Il6 (interleukin 6) [NCBI Gene 24498] {aka ILg6, Ifnb2}, EGF (epidermal growth factor) [NCBI Gene 1950] {aka HOMG4, URG}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, Syt1 (synaptotagmin 1) [NCBI Gene 25716] {aka P65}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, Mtor (mechanistic target of rapamycin kinase) [NCBI Gene 56718] {aka Frap1, RAFT1}, Ocln (occludin) [NCBI Gene 83497], Trpv1 (transient receptor potential cation channel, subfamily V, member 1) [NCBI Gene 83810] {aka TRPV1_SON, VR.5'sv, Vr1, Vr1l1}, Cat (catalase) [NCBI Gene 24248] {aka CS1, Cas1, Cat01, Catl, Cs-1}, Cldn1 (claudin 1) [NCBI Gene 65129], Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 24383] {aka BARS-38, Gapd}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, Nfe2l2 (nuclear factor, erythroid derived 2, like 2) [NCBI Gene 18024] {aka Nrf2}, Slc7a11 (solute carrier family 7 member 11) [NCBI Gene 310392], Hmox1 (heme oxygenase 1) [NCBI Gene 24451] {aka HEOXG, Heox, Hmox, Ho-1, Ho1, hsp32}, OCLN (occludin) [NCBI Gene 100506658] {aka BLCPMG, PPP1R115, PTORCH1}, Tp53 (tumor protein p53) [NCBI Gene 24842] {aka Trp53, p53}, Fth1 (ferritin heavy chain 1) [NCBI Gene 25319] {aka Fth}, Tnf (tumor necrosis factor) [NCBI Gene 24835] {aka RATTNF, TNF-alpha, Tnfa}, Sod2 (superoxide dismutase 2) [NCBI Gene 24787] {aka MnSOD}, Pik3cb (phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta) [NCBI Gene 85243], Muc6 (mucin 6, oligomeric mucus/gel-forming) [NCBI Gene 282586], Gpx4 (glutathione peroxidase 4) [NCBI Gene 29328] {aka Gshpx-4, Phgpx, gpx-4, snGpx}, Il1b (interleukin 1 beta) [NCBI Gene 24494] {aka IL-1F2}, Nfe2l2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 83619], Bcl2 (BCL2, apoptosis regulator) [NCBI Gene 24224] {aka Bcl-2}, Acsl4 (acyl-CoA synthetase long-chain family member 4) [NCBI Gene 50790] {aka 9430020A05Rik, ACS4, Facl4, Lacs4}, TJP1 (tight junction protein 1) [NCBI Gene 7082] {aka ZO-1}, Rela (Rela proto-oncogene, NFKB subunit) [NCBI Gene 19697] {aka p65, p65 NF-kappa B, p65 NFkB}, MUC6 (mucin 6, oligomeric mucus/gel-forming (gene/pseudogene)) [NCBI Gene 4588] {aka MUC-6}, Egf (epidermal growth factor) [NCBI Gene 25313], COX8A (cytochrome c oxidase subunit 8A) [NCBI Gene 1351] {aka COX, COX8, COX8-2, COX8L, MC4DN15, VIII}, ALOX15 (arachidonate 15-lipoxygenase) [NCBI Gene 246] {aka 12-LOX, 15-LOX, 15-LOX-1, LOG15}, Ptgs2 (prostaglandin-endoperoxide synthase 2) [NCBI Gene 29527] {aka COX-2, Cox2, PGHS-2, PHS II, Pghs2}, GPX4 (glutathione peroxidase 4) [NCBI Gene 2879] {aka GPx-4, GSHPx-4, MCSP, PHGPx, SMDS, snGPx}, Acsl4 (acyl-CoA synthetase long-chain family member 4) [NCBI Gene 113976] {aka Acs4, Facl4}, CAT (catalase) [NCBI Gene 847], Gpx1 (glutathione peroxidase 1) [NCBI Gene 24404] {aka GSHPx, GSHPx-1}, Keap1 (Kelch-like ECH-associated protein 1) [NCBI Gene 117519] {aka Inrf2}, CLDN1 (claudin 1) [NCBI Gene 9076] {aka CLD1, ILVASC, SEMP1}, COX1 (cytochrome c oxidase subunit I) [NCBI Gene 26195] {aka COI}, Lpo (lactoperoxidase) [NCBI Gene 287610], Actb (actin, beta) [NCBI Gene 81822] {aka Actx}, Gpx4 (glutathione peroxidase 4) [NCBI Gene 625249] {aka GPx-4, GSHPx-4, PHGPx, mtPHGPx, snGPx}, SOD1 (superoxide dismutase 1) [NCBI Gene 6647] {aka ALS, ALS1, HEL-S-44, IPOA, SOD, STAHP}, NFE2L2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 4780] {aka IMDDHH, NRF2, Nrf-2}, ACSL4 (acyl-CoA synthetase long chain family member 4) [NCBI Gene 2182] {aka ACS4, FACL4, LACS4, MRX63, MRX68, XLID63}, Nox4 (NADPH oxidase 4) [NCBI Gene 85431], Tjp1 (tight junction protein 1) [NCBI Gene 292994] {aka ZO-1}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, Vegfa (vascular endothelial growth factor A) [NCBI Gene 83785] {aka VEGF-A, VEGF111, VEGF164, VPF, Vegf}, Akt1 (AKT serine/threonine kinase 1) [NCBI Gene 24185] {aka Akt}, Alox15 (arachidonate 15-lipoxygenase) [NCBI Gene 81639] {aka 12-LOX, 15-LOX, Alox12, Alox12l}
- **Diseases:** vomiting (MESH:D014839), gastric cancer (MESH:D013274), bleeding (MESH:D006470), dysbiosis (MESH:D064806), renal failure (MESH:D051437), chronic kidney disease (MESH:D051436), Edema (MESH:D004487), atrophy (MESH:D001284), platelet function (MESH:D001791), GU (MESH:D013276), injury to (MESH:D014947), Inflammation (MESH:D007249), mitochondrial dysfunction (MESH:D028361), Helicobacter pylori infection (MESH:D016481), necrosis (MESH:D009336), gastrointestinal bleeding (MESH:D006471), Mucosal Injury (MESH:D052016), inflammatory cytokines (MESH:D000080424), Gastric Mucosal Injury (MESH:D013272), constipation (MESH:D003248), allergic reactions (MESH:D004342), perforation (MESH:D057112), gastrointestinal diseases (MESH:D005767), ulcer (MESH:D014456), vascular damage (MESH:D057772), Cytotoxicity (MESH:D064420), malabsorption (MESH:D008286)
- **Chemicals:** Glutamate (MESH:D018698), hydrochloric acid (MESH:D006851), Biotin (MESH:D001710), hydroxyl radicals (MESH:D017665), Anhydrous ethanol (MESH:D000431), kaempferol (MESH:C006552), CCK-8 (MESH:D012844), Aspirin (MESH:D001241), Water (MESH:D014867), Spermine (MESH:D013096), DCFH-DA (MESH:C029569), iron (MESH:D007501), Arachidonic acid (MESH:D016718), prostaglandin (MESH:D011453), nitrogen (MESH:D009584), lipid hydroperoxides (MESH:D008054), sodium pentobarbital (MESH:D010424), (R)-Sulforaphane (MESH:C016766), Costunolide (MESH:C002602), PAS (MESH:D011478), Pyruvate (MESH:D019289), Methionine (MESH:D008715), metal (MESH:D008670), paraffin (MESH:D010232), Ferrostatin-1 (MESH:C573944), oxygen (MESH:D010100), maltodextrin (MESH:C008315), Spermidine (MESH:D013095), alcohol (MESH:D000438), hydrogen (MESH:D006859), eosin (MESH:D004801), luteolin (MESH:D047311), Sphingolipid (MESH:D013107), selenocysteine (MESH:D017279), ROS (MESH:D017382), paraquat (MESH:D010269), Eugenol (MESH:D005054), CO2 (MESH:D002245), GSH (MESH:D005978), CMC (MESH:D002266), Beta-Alanine (MESH:D015091), Pantothenate (MESH:D010205), Pyruvaldehyde (MESH:D011765), OH (MESH:C031356), Lipid (MESH:D008055), paraformaldehyde (MESH:C003043), Hoechst 33342 (MESH:C017807), Omeprazole (MESH:D009853), Magnolol (MESH:C005498), bicarbonate (MESH:D001639), MDA (MESH:D008315), CoA (MESH:D003065), bile acid (MESH:D001647), H&amp;E (MESH:D006371), H2O2 (MESH:D006861), AEE (MESH:C575435), superoxide anion (MESH:D013481), BODIPY 581/591 C11 (-), Na (MESH:D012964), hematoxylin (MESH:D006416)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606], Kaempferia galanga (galangal, species) [taxon 97750]
- **Mutations:** S0033S
- **Cell lines:** GES-1 — Homo sapiens (Human), Transformed cell line (CVCL_EQ22), GSE-1 — Konosirus punctatus (Dotted gizzard shad), Spontaneously immortalized cell line (CVCL_6F81), AUS- — Homo sapiens (Human), Werner syndrome, Transformed cell line (CVCL_VI09), S2 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232), RSL-3 — Mus musculus (Mouse), Hybridoma (CVCL_C6V6)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12937677/full.md

## Figures

11 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12937677/full.md

## References

71 references — full list in the complete paper: https://tomesphere.com/paper/PMC12937677/full.md

---
Source: https://tomesphere.com/paper/PMC12937677